Management Team

President

International entrepreneur with 40 years of leadership in the healthcare business.

He successfully created high-value niches in healthcare. Throughout his career, he built up, developed, and sold businesses worth hundreds of millions of dollars

Business Developement

Screenshot 2026-02-05 at 14.38_edited.jpg

Over 15 years of European business development experience, with a strong network of healthcare providers and professionals. Holds a deep understanding of oncology market needs and is a trained Medical Doctor specializing in Internal Medicine.

Business Analyst

Screenshot 2026-02-05 at 14.38_edited.png

Over 20 years of business development experience in international healthcare enterprises, successfully building cross-industry partnerships and fostering strong relationships with strategic healthcare stakeholders, with a particular focus on the European market.

Analyst

Bring his experience in project and team management in self-sustained farming and business to add a more 'down to earth' point of view to Orot's journey and business approach.

Advisory Board

Barbara Werchowiecka-Rusinek

Former Group CEO of Amethyst Radiotherapy

Barbara is an experienced manager in the private healthcare sector, specializing in medical services, oncology, and radiotherapy. She is the former creator and operations manager of a network of dialysis therapy centers, and has held leadership roles such as Country Manager (Poland) and Group CEO at Amethyst Radiotherapy, and Deputy Chairman of NuMed. Barbara is an expert in expanding access to advanced cancer treatments across Eastern Europe.

“A holistic approach to the patient is an important element of our work”

Ohad Shaked

CEO & Co-Founder of ThinkUp | Former Co-Owner of 888 Holdings

Ohad is a serial entrepreneur and investor with over 20 years of experience in high-growth tech companies (Former Co-Owner of 888 Holdings). As the CEO and Co-Founder of ThinkUp, he helps entrepreneurs transform innovative ideas into successful startups. He is also actively involved in transformative oncology research and investments.

“Being acknowledged of someone who changed the world, who made something exceptional - that's what drives me”

Amir Perelman

Founder of Perelman Trade E.B.R | Medical Qigong Israel

Amir is an expert in evidence-based integrative medicine and the founder of EBR - a natural remedies company providing knowledge and tools for healing through natural ways, based on science and research. He is a Qigong master and the founder of Medical Qigong Israel. Amir is also a musician and an acclaimed lecturer in the field of natural health in Israel and abroad

“We believe that combining the best of both worlds—complementary medicine and integrative medicine—is the right approach.”

Dr. Opher Caspi, MD, PhD

Director of Integrative Medicine and Cancer Survivorship Programs at the Davidoff Cancer Center, Rabin Medical Center

Opher is the Director of Integrative Medicine and Cancer Survivorship Programs at the Davidoff Cancer Center, Rabin Medical Center, Israel. A board-certified internist with more than 30 years of clinical and research experience in integrative medicine. He focuses on the patient as a whole - the integration of complementary and alternative medicine to enhance its effectiveness, and reduce the side effects and costs of conventional medicine. The author of the forthcoming "Textbook of Integrative Oncology” and a co-founder of MENTOR, a startup using extended reality as mental acceleration to enhance therapeutic outcomes and reduce healthcare costs

Barbara is an experienced manager in the private healthcare sector, specializing in medical services, oncology, and radiotherapy. She is the former creator and operations manager of a network of dialysis therapy centers, and has held leadership roles such as Country Manager (Poland) and Group CEO at Amethyst Radiotherapy, and Deputy Chairman of NuMed. Barbara is an expert in expanding access to advanced cancer treatments across Eastern Europe.

"Complementary medicine is not an "alternative" to cancer treatment, but rather an additional tool in the comprehensive treatment of the disease.”

Dikla Sharon

Clinical Development Expert | Former Director at Takeda

Dikla is a clinical development consultant with over 18 years of experience in guiding drug products from first-in-human trials through regulatory approval. She is an expert in rare disease programs, translating complex requirements into clear, actionable plans. Dikla has held leadership positions at Takeda (formerly Shire), Baxalta Innovations, and Micreos Pharmaceuticals.

Barbara is an experienced manager in the private healthcare sector, specializing in medical services, oncology, and radiotherapy. She is the former creator and operations manager of a network of dialysis therapy centers, and has held leadership roles such as Country Manager (Poland) and Group CEO at Amethyst Radiotherapy, and Deputy Chairman of NuMed. Barbara is an expert in expanding access to advanced cancer treatments across Eastern Europe.

"I'm intrigued by the evolving landscape of scientific innovation and focused on translating technological advances into meaningful patient impact"

Dr. Marcela Karpuj

Expert in Infectious Diseases and Translational Medicine | Associate Professor at Braude Academic College

Marcela brings over 25 years of academic and industry experience spanning Israel and the United States. Her expertise covers infectious diseases, oncology, and neurodegenerative disorders, with a strong focus on translational medicine and applied research. She previously served as Head of the Genome Technology Center at the Faculty of Medicine, Bar-Ilan University, where she led interdisciplinary research integrating genomics and drug discovery. Throughout her career, she has contributed to multiple drug development programs and clinical research initiatives and is a co-inventor on several U.S. patents.

Barbara is an experienced manager in the private healthcare sector, specializing in medical services, oncology, and radiotherapy. She is the former creator and operations manager of a network of dialysis therapy centers, and has held leadership roles such as Country Manager (Poland) and Group CEO at Amethyst Radiotherapy, and Deputy Chairman of NuMed. Barbara is an expert in expanding access to advanced cancer treatments across Eastern Europe.